Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Self-citationDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 3
- CELL 78: 23 (1994).
- Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
- Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).
Cited by
Items 501–600 of 885
Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
Tomczyk, M., Glaser, T., Ulrich, H., Slominska, E. M., & Smolenski, R. T. (2020) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2020.1815769 · Cited by 12
Huntingtin is localized in the nucleus during preimplanatation embryo development in mice
Jeong, S., Kim, M., Chang, K.-A., Kim, H., Park, C., & Suh, Y. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.10.001 · Cited by 12
Pathogenesis of Polyglutamine-Induced Disease: A Model for SCA1
Klement, I. A., Zoghbi, H. Y., & Orr, H. T. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2801 · Cited by 12
Pathogenesis of Polyglutamine Diseases
Pennuto, M., & Sambataro, F. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0021486 · Cited by 12
Huntingtin confers fitness but is not embryonically essential in zebrafish development
Sidik, H., Ang, C. J., & Pouladi, M. A. (2019) · Developmental Biology · doi:10.1016/j.ydbio.2019.10.037 · Cited by 11
Cellular Models: HD Patient-Derived Pluripotent Stem Cells
Smith-Geater, C., Hernandez, S. J., Thompson, L. M., & Mattis, V. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_4 · Cited by 11
Localization of huntingtin-interacting protein-2 (Hip-2) mRNA in the developing mouse brain
Tanno, Y., Mori, T., Yokoya, S., Kanazawa, K., Honma, Y., Nikaido, T., Takeda, J., Tojo, M., Yamamoto, T., & Wanaka, A. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00030-7 · Cited by 11
Mouse Mutagenesis and Disease Models for Neuropsychiatric Disorders
Gondo, Y., Murata, T., Makino, S., Fukumura, R., & Ishitsuka, Y. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_106 · Cited by 11
Ferlazzo, G. M., Gambetta, A. M., Amato, S., Cannizzaro, N., Angiolillo, S., Arboit, M., Diamante, L., Carbognin, E., Romani, P., Torre, F. L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39552-9 · Cited by 10
Huntingtin loss in hepatocytes is associated with altered metabolism, adhesion, and liver zonation
Bragg, R. M., Coffey, S. R., Cantle, J. P., Hu, S., Singh, S., Legg, S. R. W., McHugh, C. A., Toor, A., Zeitlin, S. O., Kwak, S., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302098 · Cited by 10
Louessard, M., Cailleret, M., Jarrige, M., Bigarreau, J., Lenoir, S., Dufour, N., Rey, M. J., Saudou, F., Déglon, N., & Perrier, A. L. (2024) · Journal of Huntington s Disease · doi:10.3233/jhd-231509 · Cited by 10
Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease
Cepeda, C., Holley, S. M., Barry, J., Oikonomou, K. D., Yazon, V.-W., Peng, A., Argueta, D., & Levine, M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106752 · Cited by 10
Basu, M., Bhattacharyya, N. P., & Mohanty, P. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064838 · Cited by 10
Amyloid Fibril Formation by a Domain of Rat Cell Adhesion Molecule
Carroll, A. R., Yang, W., Ye, Y., Simmons, R. B., & Yang, J. J. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:2:241 · Cited by 10
Instabilities of Triplet Repeats: Factors and Mechanisms
Wells, R. D., Bacolla, A., & Bowater, R. P. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69680-3_4 · Cited by 10
Prowse, E. N. P., Chaudhary, A. R., Sharon, D. M., & Hendricks, A. G. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.02.006 · Cited by 9
Transgenic Model for the Study of Oxidative Damage in Huntington’s Disease
Segovia, J. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)53061-5 · Cited by 9
Treatment of Huntington’s disease with a pan-HTT-targeting CRISPR nuclease
Tan, K., Siller, D. D. B., Xiong, A. Y., Wang, A. X. A., McCallister, T. X., Mummadi, S., John, L. A. S., Lee, T. K., Carrillo, A., Renshaw, D. G., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.038 · Cited by 8
Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons
Stocksdale, J. T., Leventhal, M. J., Lam, S., Xu, Y., Wang, Y., Wang, K. Q., Thomas, R., Faghihmonzavi, Z., Raghav, Y., Smith-Geater, C., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106914 · Cited by 8
Yu, M. S., & Tanese, N. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00033 · Cited by 8
Regio, S., Vachey, G., Goñi, E., Duarte, F. T., Rybarikova, M., Sipion, M., Rey, M. J., Huarte, M., & Déglon, N. (2023) · Brain Communications · doi:10.1093/braincomms/fcad344 · Cited by 8
Identification of a long huntingtin mRNA transcript in mouse brain
Casanova, E., Alonso‐Llamazares, A., Zamanillo, D., Garate, C., Calvo, P., & Chinchetru, M. A. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00701-9 · Cited by 8
Hartlage‐Rübsamen, M., Ratz, V., Zeitschel, U., Finzel, L., Machner, L., Köppen, J., Schulze, A., Demuth, H., von Hörsten, S., Höfling, C., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0726-2 · Cited by 8
Drosophila as a model to study human brain degenerative diseases
Min, K. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00053-5 · Cited by 8
Rodan, L. H., Cohen, J., Fatemi, A. S., Gillis, T., Lucente, D. E., Gusella, J. F., & Picker, J. D. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.112 · Cited by 8
Self-citationKim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7
Huntingtin CAG-expansion mutation results in a dominant negative effect
Laundos, T. L., Li, S., Cheang, E., Santis, R. D., Piccolo, F. M., & Brivanlou, A. H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1252521 · Cited by 7
Lebouc, M., Bonamy, L., Dhellemmes, T., Scharnholz, J., Richard, Q., Courtand, G., Brochard, A., Martins, F., Landry, M., Baufreton, J., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106874 · Cited by 7
Hunting for the function of Huntingtin
Zheng, Q., & Joinnides, M. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.003376 · Cited by 7
Fouling-release Property of Water-filled Porous Elastomers
Xie, L., Hong, F., He, C., Liu, J., & Wu, C. (2012) · Chinese Journal of Chemical Physics · doi:10.1088/1674-0068/25/03/330-334 · Cited by 7
Dey, A. (2017) · Wiley eBooks · doi:10.1002/9783527803781.ch8 · Cited by 7
Genetics of subthalamic nucleus in development and disease
Philips, S. T., Albin, R. L., & Martin, D. M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.008 · Cited by 7
Of mice and men: solving the molecular mysteries of Huntington's disease
Shelbourne, P. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640617.x · Cited by 7
Shen, K., & Frydman, J. (2012) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-27928-7_10 · Cited by 6
Genome editing in stem cells for genetic neurodisorders
Dell’Amico, C., Tata, A., Pellegrino, E., Onorati, M., & Conti, L. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.006 · Cited by 6
The biology of Huntington's disease
Saudou, F., & Humbert, S. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01257-2 · Cited by 6
The impact of genomics on mammalian neurobiology
Hochgeschwender, U., & Brennan, M. B. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199902)21:2<157::aid-bies9>3.0.co;2-0 · Cited by 6
Neuronal Death in Huntington’s Disease: Multiple Pathways for One Issue?
Humbert, S., & Saudou, F. (2001) · Research and perspectives in neurosciences · doi:10.1007/978-3-662-04333-2_11 · Cited by 6
Huntington's as a developmental disorder: Molecular and neuropathologic considerations
Shin, M. R., & Hefti, M. M. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251395783 · Cited by 5
Dinamarca, M. C., Colombo, L., Tousiaki, N. E., Müller, M. M., & Pecho‐Vrieseling, E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.916019 · Cited by 5
Huntington’s disease and brain development
Humbert, S., & Barnat, M. (2022) · Comptes Rendus Biologies · doi:10.5802/crbiol.93 · Cited by 5
Huntingtin plays an essential role in the adult hippocampus
Barron, J. C., Dawson, L. J., Carew, S. J., Grace, M. C., Senior, K. A., Ryan, K. C., Nafar, F., Moore, C. S., Blundell, J. J., & Parsons, M. P. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106810 · Cited by 5
Visualization of Muscle Activity During Squat Motion for Skill Education
Yanai, K., An, Q., Ishikawa, Y., Nakagawa, J., Wen, W., Yamakawa, H., Yamashita, A., & Asama, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55861-3_14 · Cited by 5
Huntington’s Disease: From the Physiological Function of Huntingtin to the Disease
Borgs, L., Juliette, D. L., Malgrange, B., & Nguye, L. (2012) · InTech eBooks · doi:10.5772/31789 · Cited by 5
RetractedA link between chromatin condensation mechanisms and Huntington's disease: connecting the dots
Lokhande, S., Patra, B. N., & Ray, A. (2016) · Molecular BioSystems · doi:10.1039/c6mb00598e · Cited by 5
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 5
Stress and Glucocorticoids as Experience-Dependent Modulators of Huntington's Disease
Mo, C., Renoir, T., & Hannan, A. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813146-6.00020-5 · Cited by 5
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5
Proteolytic Targets in Cell Death
Watters, D. J., & Waterhouse, N. J. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69185-3_2 · Cited by 5
Andersen, J. K. (1998) · Frontiers in bioscience · doi:10.2741/a259 · Cited by 5
Nucleation of polyglutamine amyloid fibres modelling using molecular dynamics
Elliott, J. A., STARIKOV, E. B., Crawshaw, J., Claiden, P., Nilsson, L., & Windle, A. H. (2006) · Elsevier eBooks · doi:10.1016/b978-044452220-7/50075-7 · Cited by 5
Transgenic Mouse Models of Huntington’s Disease
Bates, G. P., Mangiarini, L., & Davies, S. W. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_18 · Cited by 5
Brain organoid models of Huntington's disease shift the focus towards neurodevelopment
Xu, W., & Prigione, A. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052510 · Cited by 4
Gene editing for HD: Therapeutic prospects
Chen, R. Z., & Vogt, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00021-2 · Cited by 4
Durable HTT silencing using non-evolved dCas9 epigenome editors in patient-derived cells
Waldo, J. J., Halmai, J. A. N. M., Singh, A., Gonzalez, C. E., Chen, Y., Carthen, S. A., Nolta, J. A., & Fink, K. D. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102561 · Cited by 4
From huntingtin gene to Huntington’s disease-altering strategies
Déglon, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00010-5 · Cited by 4
Hirose, A., Katagiri, S., Hayashi, T., Matsuura, T., Nagai, N., Fujinami, K., Iwata, T., & Tsunoda, K. (2020) · Documenta Ophthalmologica · doi:10.1007/s10633-020-09782-z · Cited by 4
Linking Huntington disease, brain-derived neurotrophic factor, and depressive-like behaviors
Plácido, E., Nascimento-Castro, C. D. P., Welter, P. G., Gil‐Mohapel, J., & Brocardo, P. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00042-8 · Cited by 4
Characterization of a Knock-In Mouse Model with a Huntingtin Exon 1 Deletion
Braatz, E. M., André, E. A., Liu, J.-P., & Zeitlin, S. O. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-210494 · Cited by 4
Description of the First Registered Case of Lopes–Maciel–Rodan Syndrome in Russia
Koshevaya, Y. S., Викторович, К. А., Buchinskaia, N. V., Pechnikova, V. V., Serebryakova, E. A., Koroteev, A. L., Glotov, A. S., & Glotov, O. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012437 · Cited by 4
Therapeutic strategies in Huntington?s disease
Alberch, J., Canals, J. M., & Pérez‐Navarro, E. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.449 · Cited by 4
Use of Genetically Engineered Mice As Models for Understanding Human Neurodegenerative Disease
Andersen, J. K., & Jurma, O. P. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01839.x · Cited by 4
Chromatin remodeler BRG1 recruits huntingtin to repair DNA double-strand breaks in neuronsPreprint
Pradhan, S., Bush, K. M., Zhang, N., PANDITA, R. K., Tsai, C.-L., Smith-Geater, C., Pandlebury, D. F., Gaikwad, S., Leonard, F., Nie, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.19.613927 · Cited by 4
Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy
Krzystek, T. J., & Gunawardena, S. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2472450 · Cited by 3
Animal models of Huntington's disease. Pros and cons
Stepanova, P., Voutilainen, M. H., Eriksson, O., & Lindholm, D. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101149 · Cited by 3
Alexander Disease and Astrotherapeutics
Brenner, M., & Messing, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_5 · Cited by 3
Huntingtin Decreases Susceptibility to a Spontaneous Seizure Disorder in FVN/B Mice
Raamsdonk, J. M. V., Al-Shekaili, H. H., Wagner, L. A., Bredy, T. W., Chan, L., Pearson, J., Schwab, C., Murphy, Z., Devon, R. S., Lu, G., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0423 · Cited by 3
Araldi, R. P., Pinto, J. R. D., & Kerkis, I. (2025) · Brain Sciences · doi:10.3390/brainsci15080865 · Cited by 3
Huntington's Disease and Other Choreas
Salman, H., Wild, E. J., & Tabrizi, S. J. (2017) · Wiley eBooks · doi:10.1002/9781118661895.ch21 · Cited by 3
Mouse Models for Human Diseases by Forward and Reverse Genetics
Gondo, Y. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00034-8 · Cited by 3
Aggregate-centered redistribution of proteins by mutant huntingtin
Swayne, L. A., & Braun, J. E. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.129 · Cited by 3
Molecular Pathology of Huntington's Disease: Animal Models and Nuclear Mechanisms
Mangiarini, L., Sathasivam, K., & Bates, G. P. (1999) · The Neuroscientist · doi:10.1177/107385849900500613 · Cited by 3
Tavares, K. C. S., Pinho, R. D. M. E., Carneiro, I. D. S., de Aguiar, L. H., Calderón, C. E. M., Martins, L. T., Ambrósio, C. E., Maga, E. A., Bertolini, M., Murray, J. D., et al. (2012) · ACTA SCIENTIAE VETERINARIAE · Cited by 3
CNS genetic disorders: loss of function, gain of function, or something else?
Martin, J. B. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80074-3 · Cited by 3
West, A. B., Gray, M., & Standaert, D. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00123-3 · Cited by 3
Forward and Reverse Genetics to Model Human Diseases in the Mouse
Gondo, Y., Makino, S., & Fukumura, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00028-0 · Cited by 3
Degeneration Versus Development: Hunting-Out the D-Unit of Huntington’s Disease
Lu, S., & Lu, B. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00649-0 · Cited by 3
Koinzidenz von Chorea Huntington und Epilepsie
Bengel, D., Supprian, T., & Lesch, K. (1997) · Der Nervenarzt · doi:10.1007/s001150050123 · Cited by 3
Hyrskyluoto, A. (2014) · Helda - University of Helsinki Institutional Repository · Cited by 3
Bylsma, F. (1997) · Critical issues in neuropsychology · doi:10.1007/978-1-4899-1857-4_16 · Cited by 3
Gene Therapy of Huntington’s Disease
Isacson, O., & Haque, N. S. K. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-478-8_21 · Cited by 3
Brouillet, E. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-021-00927-4 · Cited by 3
Brain structure and function in juvenile onset Huntington's disease
Tereshchenko, A., Nopoulos, P., Boes, A. D., Moser, D. J., Narayanan, N. S., & Kamholz, J. (2020) · doi:10.17077/etd.005279 · Cited by 3
Bettess, M. D. (2001) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 3
Study of vesicular glycolysis in health and Huntington's Disease
Cluskey, M. M. (2021) · theses.fr (ABES) · doi:10.70675/eb022640z9c3cz4467z940dz6b27765c296b · Cited by 3
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“Similar to α -syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β -sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
Huntingtin reduction results in altered nuclear structure and heterochromatic instability
Barron, J. C., Coady, S. T., Fleming, A. C., Carew, S. J., Taylor, M. C. A., Hurley, E. P., Nafar, F., & Parsons, M. P. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf126 · Cited by 2
Caron, N. S., Fan, J., Ma, D., Yung, A. C., Ko, S., Bale, K., Anderson, C., Kozłowski, P., Pouladi, M. A., Wellington, C. L., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102710 · Cited by 2
Exploring huntington's disease from a neurodevelopmental perspective
Huang, C., Zheng, X., Li, W., Zhang, Z., Li, S., Li, X., Rong, M., & Yan, S. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.124552 · Cited by 2
Inositol 1,4,5-Tripshosphate Receptor, Calcium Signaling, and Polyglutamine Expansion Disorders
Борисович, Б. И. (2010) · Current topics in membranes · doi:10.1016/s1063-5823(10)66014-0 · Cited by 2
Agarwood Branch Ethanolic Extract Affects Expression of Apoptotic Genes in MCF-7 Breast Cancer Cells
Abbas, P., Samsudin, N., Ishak, N. I., Salleh, H. M., Azziz, S. S. S. A., Alkhatib, M. F. R., & Hashim, Y. Z. H.-Y. (2021) · Progress in Drug Discovery & Biomedical Science · doi:10.36877/pddbs.a0000239 · Cited by 2
Manganese and Huntington Disease
Tidball, A. M., Bichell, T. J., & Bowman, A. B. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00540 · Cited by 2
Animal Models for Huntington's Disease
Ortega, Z., & Lucas, J. J. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00214 · Cited by 2
Wild, E. J., & Tabrizi, S. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.006 · Cited by 2
Chapter 2 The Biology of Trinucleotide Repeat Disorders
Reddy, P. H., & Tagle, D. A. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60022-x · Cited by 2
Molecular Pathogenesis and Therapeutic Targets in Huntington's Disease
Bett, J. S., Bates, G. P., & Hockly, E. (2006) · Elsevier eBooks · doi:10.1016/b978-012369462-1/50015-6 · Cited by 2
Barker, R. A., & Priller, J. (2003) · The biomedical & life sciences collection. · doi:10.1093/brain/awh011 · Cited by 2
Huntington's Disease and related disorders and their association with schizophrenia-like psychosis
Sachdev, P. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511789977.029 · Cited by 2
Cellular and Molecular Mechanisms of Neuronal Dysfunction in Huntington's Disease
Caboche, J., Vanhoutte, P., Boussicault, L., Roze, E. F., & Bétuing, S. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00045-3 · Cited by 2
Schut, M. H., Patassini, S., Kim, E. H., Bullock, J. Y., Waldvogel, H. J., Faull, R. L. M., Pepers, B. A., den Dunnen, J. T., van Ommen, G. B., & van Roon‐Mom, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178556 · Cited by 2
Metadata
- Authors
- Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- MacDonald, Marcy E.
- Venue
- Science
- Published
- 1995-07-21
- Volume
- 269
- Issue
- 5222
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002644780
- Cited by
- 723
- References
- 29
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 21 · 2014: 33 · 2013: 22 · 2012: 32
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 16367, NS32765, R01NS032765)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Huntington's disease, huntingtin, gene targeting, embryonic lethality, gastrulation, loss of function, gain-of-function, CAG repeat expansion, mouse model, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Base Sequence, Cell Line, Ectoderm, Female, Embryonic and Fetal Development, Genotype, Heterozygote, Homozygote, Humans, Huntington Disease, Male, Mesoderm, Mice, Inbred C57BL, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Phenotype, Stem Cells, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.